Όλο το DSpace

Πλοήγηση ανά Θέμα "gamma glutamyltransferase"

Αποτελέσματα 21-28 από 28

    • Quality of life in people with multiple sclerosis receiving glatiramer acetate or interferon in Greek clinical practice 

      Mitsikostas D., Bakirtzis C., Nikolaidis I., Tsimourtou V., Kountra P., Matsi S., Papadimitriou A. (2022)
      Aim: To evaluate glatiramer acetate (GA) or IFN-β effects on quality of life (QoL) in people with relapsing/remitting multiple sclerosis (PwRRMS) in Greece. Methods: A prospective, practice-based study. QoL/function/symptoms ...

    • Quantitative HBsAg and HDV-RNA levels in chronic delta hepatitis 

      Zachou, K.; Yurdaydin, C.; Drebber, U.; Dalekos, G. N.; Erhardt, A.; Cakaloglu, Y.; Degertekin, H.; Gurel, S.; Zeuzem, S.; Bozkaya, H.; Schlaphoff, V.; Dienes, H. P.; Bock, T. C.; Manns, M. P.; Wedemeyer, H. (2010)
      Background: Hepatitis delta virus (HDV) causes severe liver disease. Aims: To investigate the quantitative HDV-RNA, HBsAg and hepatitis B virus (HBV)DNA levels in correlation to histological, biochemical and demographical ...

    • Real-World Assessment of Quality of Life in Patients with Relapsing Remitting Multiple Sclerosis Treated with Teriflunomide for Two Years: Patient-Reported Outcomes from the AURELIO Study in Greece 

      Dardiotis E., Perpati G., Borsos M., Nikolaidis I., Tzanetakos D., Deretzi G., Koutlas E., Kilidireas C., Mitsikostas D.D., Hadjigeorgiou G., Grigoriadis N., Papagiannopoulos S., Orologas A., Aggelidakis P., Antonios A., Fakas N., Papadimitriou A., Iliopoulos I., Kostadima V., Karageorgiou K., Lamprakopoulos S., Nikiforidis D., Voumvourakis K., Kaponi A., Maltezou M., Acquaviva T.P., Kerezoudi E., Balamoutsos G., Kerasnoudis A., Mitsias P., Doskas T., Maris T., Baltogiannis C., Chroni E., The AURELIO investigators (2022)
      Introduction: Multiple sclerosis (MS) is a highly heterogeneous inflammatory disease of the central nervous system. Patient-reported outcomes (PROs) in a real-world clinical setting can provide detailed information about ...

    • Real-world treatment patterns, patient-reported outcomes, and effectiveness of flexible-dosing etanercept in patients with plaque psoriasis in Greece 

      Rigopoulos D., Patsatsi A., Antoniou C., Sotiriadis D., Roussaki-Schulze A., Boubouchairopoulou N., Skiadas I., Tsekouras V., Daly A.C.H. (2022)
      Etanercept is approved for continuous or intermittent use and flexible dosing in plaque psoriasis (PsO). The objectives of this study were to investigate real-world treatment patterns with etanercept in Greek adults with ...

    • Role of exercise in the treatment of alcohol use disorders (review) 

      Manthou E., Georgakouli K., Fatouros I.G., Gianoulakis C., Theodorakis Y., Jamurtas A.Z. (2016)
      Excessive alcohol use can cause harmful effects on the human body, which are associated with serious health problems, and it can also lead to the development of alcohol use disorders (AUDs). There is certain evidence that ...

    • Role of immunohistochemistry for hepatitis D and hepatitis B virus in hepatitis delta 

      Kabaçam, G.; Wedemeyer, H.; Savaş, B.; Keskin, O.; Dalekos, G.; Tabak, F.; Idilman, R.; Erhardt, A.; Yalçin, K.; Bozdayi, M. A.; Bozkaya, H.; Manns, M.; Dienes, H.; Yurdaydin, C.; Berg, T.; Böcher, W.; Bohle, H.; Buggisch, P.; Cornberg, M.; Ers̈oz, G.; Feyerabend, S.; Hinrichsen, H.; Manok, M.; Häussinger, D.; Herzog, W.; Hofmann, W. P.; Plein, K.; Hardt, H.; Porst, H.; Mederacke, I.; Rigopoulou, E. I.; Sentürk, H.; Wagner, E. K. V. (2014)
      Background & Aims: Immunohistochemical assessment of liver tissue in chronic delta hepatitis (CDH) is underinvestigated. Aim of the study was (i) to assess variables associated with hepatitis D antigen (HDAg), hepatitis B ...

    • Serum Levels of Urokinase Plasminogen Activator Receptor (suPAR) Discriminate Moderate Uncontrolled from Severe Asthma 

      Kotsiou O.S., Pantazopoulos I., Mavrovounis G., Marsitopoulos K., Tourlakopoulos K., Kirgou P., Daniil Z., Gourgoulianis K.I. (2022)
      Introduction: The most clinically useful concept in asthma is based on the intensity of treatment required to achieve good asthma control. Biomarkers to guide therapy are needed. Aims: To investigate the role of circulating ...

    • Type 1 autoimmune hepatitis presenting with severe autoimmune neutropenia 

      Doumtsis P., Oikonomou T., Goulis I., Zachou K., Dalekos G., Cholongitas E. (2018)
      Autoimmune hepatitis (AIH) is a progressive, chronic liver disease characterized by unresolving hepatocellular inflammation of autoimmune origin. The clinical spectrum may vary from asymptomatic presentation, to non-specific ...